rs373508468
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_000815.5(GABRD):c.263C>T(p.Thr88Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000105 in 1,612,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T88T) has been classified as Benign.
Frequency
Consequence
NM_000815.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRD | NM_000815.5 | c.263C>T | p.Thr88Met | missense_variant | 4/9 | ENST00000378585.7 | NP_000806.2 | |
GABRD | XM_017000936.2 | c.968C>T | p.Thr323Met | missense_variant | 3/8 | XP_016856425.1 | ||
GABRD | XM_011541194.4 | c.302C>T | p.Thr101Met | missense_variant | 4/9 | XP_011539496.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRD | ENST00000378585.7 | c.263C>T | p.Thr88Met | missense_variant | 4/9 | 1 | NM_000815.5 | ENSP00000367848.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152258Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250536Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135736
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1460586Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 726620
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152258Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74390
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2024 | The c.263C>T (p.T88M) alteration is located in exon 4 (coding exon 4) of the GABRD gene. This alteration results from a C to T substitution at nucleotide position 263, causing the threonine (T) at amino acid position 88 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Idiopathic generalized epilepsy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 460008). This variant has not been reported in the literature in individuals affected with GABRD-related conditions. This variant is present in population databases (rs373508468, gnomAD 0.02%). This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 88 of the GABRD protein (p.Thr88Met). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at